270 related articles for article (PubMed ID: 22081106)
1. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
[TBL] [Abstract][Full Text] [Related]
2. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Puricelli WP; Nishioka NS
Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
4. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Wolfsen HC
J Clin Gastroenterol; 2005 Mar; 39(3):189-202. PubMed ID: 15718860
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus.
Ban S; Mino M; Nishioka NS; Puricelli W; Zukerberg LR; Shimizu M; Lauwers GY
Am J Surg Pathol; 2004 Nov; 28(11):1466-73. PubMed ID: 15489650
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
7. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients.
Weiss AA; Wiesinger HA; Owen D
Can J Gastroenterol; 2006 Apr; 20(4):261-4. PubMed ID: 16609754
[TBL] [Abstract][Full Text] [Related]
9. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
10. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy in Barrett's esophagus.
Overholt BF; Panjehpour M
J Clin Laser Med Surg; 1996 Oct; 14(5):245-9. PubMed ID: 9612190
[TBL] [Abstract][Full Text] [Related]
12. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Panjehpour M; Overholt BF
Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results.
Overholt BF; Panjehpour M; Halberg DL
Gastrointest Endosc; 2003 Aug; 58(2):183-8. PubMed ID: 12872083
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
Wolfsen HC
Compr Ther; 2005; 31(2):137-44. PubMed ID: 15901944
[TBL] [Abstract][Full Text] [Related]
15. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus.
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fléjou JF
Gastrointest Endosc; 2004 Jun; 59(7):880-9. PubMed ID: 15173809
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis.
Owens VL; Katzka DA; Lutzke LS; Wang KK; Smyrk TC
Dis Esophagus; 2012 Jan; 25(1):33-9. PubMed ID: 21668572
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.
Panjehpour M; Coppola D; Overholt BF; Vo-Dinh T; Overholt S
Anticancer Res; 2008; 28(1B):485-9. PubMed ID: 18383889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
